3628 results for «2129»
3628 results
CTO PCI: an evolving landscape
21 May 2026 – From EuroPCR 2026
Review the evolving landscape of chronic total occlusion (CTO) PCI with a focus on recent trends, contemporary management in multivessel disease, and innovative techniques such as retrograde approaches and titrated contrast recanalization. This session also addresses cost-effectiveness and drug-coated balloon (DCB) therapy outcomes from multicenter studies.
TAVI: LIVE Educational Case from Cleveland Clinic - London, UK
22 May 2026 – From EuroPCR 2026
This educational session from the Cleveland Clinic focuses on transcatheter aortic valve implantation (TAVI) in patients with significant landing zone calcification. It presents a detailed operator strategy and live case demonstrating the optimal use of a third generation intra-annular self-expanding valve, alongside approaches to coronary artery...
Challenging procedures for bifurcation lesions
22 May 2026 – From EuroPCR 2026
Explore a series of challenging cases in coronary bifurcation interventions, highlighting complex decision-making scenarios, pharmaco-invasive strategies guided by IVUS, and tailored techniques for reintervention. Emphasis is placed on imaging-guided PCI and simplifying complex double bifurcation and long lesion treatments to optimize patient outcomes.
Beyond stent: use of DCB in CTO
22 May 2026 – From EuroPCR 2026
This session focuses on the innovative use of drug-coated balloons (DCB) in chronic total occlusion (CTO) interventions. It reviews combined plaque modification techniques, complex multivessel PCI cases involving CTOs, and strategy considerations such as hybrid therapy versus full metal jacket, emphasizing vessel biology preservation during revascularisation.
Best coronary complications
22 May 2026 – From EuroPCR 2026
A collection of challenging coronary complication cases is presented, including management of stuck wires in calcific CTOs, complex PCI scenarios with unexpected twists, techniques for puncturing seals, and dealing with microaxial pump kinks, providing valuable lessons in complication management during interventional procedures.
In-stent restenosis: exploring novel solution for an old problem
22 May 2026 – From EuroPCR 2026
This session explores innovative approaches to treating in-stent restenosis (ISR) with a focus on drug-coated balloons (DCB) and sirolimus or paclitaxel-eluting balloon catheters. It includes clinical outcomes from IVUS-guided procedures, cutting balloon angioplasty, comparisons between DCB and DES, and emerging machine learning tools to predict target-lesion...
All you need to know - Intracoronary imaging for vulnerable plaque
22 May 2026 – From EuroPCR 2026
This session provides a comprehensive overview of vulnerable plaque pathophysiology and the role of intracoronary imaging in its identification. It assesses treatment options, including the potential role of preventative PCI and intensive medical therapy, to guide clinical decision-making in managing plaque vulnerability.
Is there a rule for DCB in ACS setting?
22 May 2026 – From EuroPCR 2026
This session examines the application of drug-coated balloons (DCB) in the acute coronary syndrome (ACS) setting, comparing outcomes with drug-eluting stents (DES). It discusses the impact of intraluminal thrombus, real-world registry data on DCB-first strategies in STEMI, and multicentre experiences with DCB use in STEMI and...
How should I treat my CTO? Adapting to local conditions
22 May 2026 – From EuroPCR 2026
This session delves into managing chronic total occlusions (CTO) under resource-limited conditions, highlighting the essential CTO toolbox and strategic procedural planning. It emphasizes that an antegrade-first approach, often with dual arterial access, can achieve high success in many CTO cases, illustrated through complex real-world cases from...
New insights into pharmacological treatment for STEMI
21 May 2026 – From EuroPCR 2026
This session presents the latest pharmacological advances in the treatment of ST-segment elevation myocardial infarction (STEMI). It covers safety data on ticagrelor monotherapy post-primary PCI, the impact of P2Y12 inhibitor pretreatment, effects of dapagliflozin on myocardial remodeling, and considerations for bleeding risk and vascular preparation strategies...
Challenges in treating tricuspid regurgitation
22 May 2026 – From EuroPCR 2026
This session addresses the complexities of treating tricuspid regurgitation, offering insights into tailored treatment options and complication management. Through detailed case studies from China and Germany, it highlights practical approaches and bailout strategies for tricuspid valve interventions.
Spontaneous coronary artery dissection management with intracoronary imaging
22 May 2026 – From EuroPCR 2026
Explore the nuanced management of spontaneous coronary artery dissection (SCAD) with a focus on intracoronary imaging. This session examines diagnostic challenges, the limited role of coronary CT angiography, and strategies for managing occlusive SCAD cases, highlighting the evolving understanding of this complex condition.
How to treat aortic regurgitation
22 May 2026 – From EuroPCR 2026
Explore cutting-edge transcatheter approaches for aortic regurgitation, including first-in-human ATLAS technique, management in LVAD patients, and off-label Myval use. This session reviews clinical challenges and innovative solutions in aortic valve interventions, offering valuable insights from complex procedural experiences.
Asymptomatic high-risk patients: can CT coronary angiography improve our practice?
21 May 2026 – From EuroPCR 2026
This session examines the role of cardiac computed tomography (CT) coronary angiography in improving clinical practice for asymptomatic high-risk patients. It discusses detection of vulnerable plaque features, the importance of inflammation and physiology in risk assessment, and explores individualized treatment pathways including PCI, medical therapy, or...
Publishing in interventional cardiology: aligning authors, editors and impact
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive perspective on publishing in interventional cardiology by aligning the expectations of authors, editors, reviewers, and readers. It addresses differences in paper interpretation, common misalignments between scientific intent and editorial outcomes, and strategies to enhance clarity, relevance, and impact of scientific publications.
Transcatheter rescue in cardiogenic shock
20 May 2026 – From EuroPCR 2026
This session presents cutting-edge transcatheter rescue interventions in cardiogenic shock scenarios. It covers emergent valve-in-valve procedures, hybrid approaches for valvular heart disease with heart failure, management of ventricular septal rupture post-myocardial infarction, and percutaneous closure techniques for high-risk patients, emphasizing lifesaving interventional strategies.
Complex distal LM PCI challenges (trifurcations and more)
20 May 2026 – From EuroPCR 2026
Focusing on the intricacies of complex distal left main PCI, this session covers challenging trifurcation lesions and emergency interventions. It includes IVUS-guided approaches for trifurcation PCI, management of calcified left main trifurcations, and multidisciplinary team rescue strategies for unstable left main bifurcation disease.
Images that speak for themselves
20 May 2026 – From EuroPCR 2026
This visually-driven session presents compelling clinical cases where imaging played a decisive role. Cases include unexpected challenges following transcatheter tricuspid valve replacement, severe hypertension in a young athlete, atypical coronary artery anatomy, critical moments of cardiac arrest, and unique coronary artery findings resembling a spider web.
Complications in CAD PCI
20 May 2026 – From EuroPCR 2026
This session focuses on the recognition and management of complications during coronary artery disease PCI. It includes cases of acute guide catheter crises, rare post-PCI chest pain etiologies, innovative stent retrieval techniques, and critical procedural challenges, providing an educational journey through complex complication management.
Innovations in structural interventions
20 May 2026 – From EuroPCR 2026
Highlighting the forefront of structural heart interventions, this session presents innovations including novel devices and technologies from industry leaders. It features advancements such as a new transseptal left atrial fixation device designed to expand the suitability of transcatheter mitral valve replacement (TMVR).